Search

Displaying results 7331 - 7340 of 10000 in total
  1. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    Darbinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor. … Darbinurad has a monoisotopic molecular weight of 324.09 Da.

  2. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    Remlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist. … Remlifanserin has a monoisotopic molecular weight of 429.22 Da.

  3. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    Envudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor. … Envudeucitinib has a monoisotopic molecular weight of 426.23 Da.

  4. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    Zemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor. … Zemprocitinib has a monoisotopic molecular weight of 345.13 Da.

  5. Drug

    Norflurane

    go.drugbank.com/drugs/DB13116
    ApprovedInvestigationalWithdrawn

    Norflurane is under investigation in clinical trial NCT01673061 (Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage).

  6. Drug

    Tasurgratinib

    go.drugbank.com/drugs/DB21222
    Investigational

    Tasurgratinib is a small molecule drug. The usage of the INN stem '-gratinib' in the name indicates that Tasurgratinib is a fibroblast growth factor receptor (FGFR) inhibitor. … Tasurgratinib is under investigation in clinical trial NCT04962867 (NCCH2006/MK010 Trial (FORTUNE Trial)). Tasurgratinib has a monoisotopic molecular weight of 587.27 Da.

  7. Drug

    Zeteletinib

    go.drugbank.com/drugs/DB21491
    Investigational

    Zeteletinib is a small molecule drug. The usage of the INN stem '-tinib' in the name indicates that Zeteletinib is a tyrosine kinase inhibitor. … Zeteletinib is under investigation in clinical trial NCT03780517 (Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors).

  8. Drug

    Xeruborbactam

    go.drugbank.com/drugs/DB21512
    Investigational

    Xeruborbactam is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Xeruborbactam is a ẞ-lactamase inhibitor. … Xeruborbactam is under investigation in clinical trial NCT07104162 (A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment).

  9. Drug

    Gridegalutamide

    go.drugbank.com/drugs/DB21593
    Investigational

    Gridegalutamide is a small molecule drug. The usage of the INN stem '-lutamide' in the name indicates that Gridegalutamide is a non-steroid antiandrogen. … Gridegalutamide is under investigation in clinical trial NCT04428788 (Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer).

  10. Drug

    Docirbrutinib

    go.drugbank.com/drugs/DB21606
    Investigational

    Docirbrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Docirbrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor. … Docirbrutinib is under investigation in clinical trial NCT05602363 (AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma).